maribavir
Takeda Pharms USA
To treat post-transplant cytomegalovirus (CMV) infection/disease that does not respond (with or without genetic mutations that cause resistance) to available antiviral treatment for CMV
The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.
git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/
Example prompts for Livtencity: